Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul 8;116(1):7-15.
doi: 10.1182/blood-2010-01-254417. Epub 2010 Mar 23.

How I treat common variable immune deficiency

Affiliations
Review

How I treat common variable immune deficiency

Charlotte Cunningham-Rundles. Blood. .

Abstract

Common variable immunodeficiency is a rare immune deficiency, characterized by low levels of serum immunoglobulin G, A, and/or M with loss of antibody production. The diagnosis is most commonly made in adults between the ages of 20 and 40 years, but both children and older adults can be found to have this immune defect. The range of clinical manifestations is broad, including acute and chronic infections, inflammatory and autoimmune disease, and an increased incidence of cancer and lymphoma. For all these reasons, the disease phenotype is both heterogeneous and complex. Contributing to the complexity is that patient cohorts are generally small, criteria used for diagnosis vary, and the doses of replacement immune globulin differ. In addition, routines for monitoring patients over the years and protocols for the use of other biologic agents for complications have not been clarified or standardized. In the past few years, data from large patient registries have revealed that both selected laboratory markers and clinical phenotyping may aid in dissecting groups of subjects into biologically relevant categories. This review presents my approach to the diagnosis and treatment of patients with common variable immunodeficiency, with suggestions for the use of laboratory biomarkers and means of monitoring patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lymphocytic pulmonary infiltrates. (A) A 40-year-old woman with gradually worsening severe lung disease. Computed tomography of the chest revealed massive infiltrates composed of lymphocytic collections and fibrotic scars. (B) On biopsy, the infiltrating T cells in the lung, obliterating normal architecture, were revealed as CD4+ by the brownish monoclonal peroxidase conjugated monoclonal anti-CD4 staining pattern (magnification ×25).
Figure 2
Figure 2
Gastrointestinal lymphoid nodules. (A) A 50-year-old woman who had a history of a duodenal ulcer, now resolved. She had a repeat gastroscopy for symptoms of gastritis; H pylori was not found. The mucosa of the stomach folds of this female patient contained numerous lymphoid follicles. (B) The jejunum of a 28-year-old male patient containing massive nodules of lymphoid hyperplasia; he had experienced a 20-lb weight loss.

References

    1. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–286. - PubMed
    1. Notarangelo LD, Fischer A, Geha RS, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124(6):1161–1178. - PMC - PubMed
    1. Janeway CA, Apt L, Gitlin D. Agammaglobulinemia. Trans Assoc Am Phys. 1953;66:200–202. - PubMed
    1. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31–42. - PubMed
    1. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34–48. - PubMed

Publication types

MeSH terms

Substances